cas 2215028-64-9|| where to buy 6-chloro-3-iodo-1-tetrahydropyran-2-yl-pyrazolo[3,4-b]pyrazine

Produktname:6-chloro-3-iodo-1-tetrahydropyran-2-yl-pyrazolo[3,4-b]pyrazine

IUPAC Name:6-chloro-3-iodo-1-(oxan-2-yl)-1H-pyrazolo[3,4-b]pyrazine

: CAS：2215028-64-9; Molekulare Formel：C10H10ClIN4O; Reinheit：95%+

Packungseinheit	Verfügbarer Vorrat	Preis($)
CM479274-1g	in stock	ƥǫȅ
CM479274-5g	in stock	ŪŞƛȖ
CM479274-10g	in stock	ŞȖȯǫ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:2215028-64-9; Molekulare Formel:C10H10ClIN4O; Schmelzpunkt:-; SMILES-Code:ClC1=CN=C2C(I)=NN(C3CCCCO3)C2=N1; Dichte:

: Katalognummer:CM479274; Molekulargewicht:364.57; Siedepunkt:; Mdl-Nr.:MFCD32220431; Lagerung:

: Pyrazolopyrazines; The pyrazolopyrazine ring system is a very interesting class of heterocyclic compounds considered as important scaffolds for many effective bioactive agents with low toxicity, antioxidant, anticonvulsant, antiparasitic, anti-inflammatory, antiviral, antibacterial, anti- Fungal and analgesic activity.

: GDC-1971; Protein tyrosine phosphatase SHP2 mediates RAS-driven MAPK signaling and has emerged in recent years as a target of interest in oncology, both for treating with a single agent and in combination with a KRAS inhibitor. GDC-1971 (formerly RLY-1971) is a SHP2 inhibitor currently in clinical trials in combination with KRAS G12C inhibitor divarasib (GDC-6036) for the treatment of solid tumors driven by a KRAS G12C mutation.